Orly Alter

Orly Alter is a USTAR Associate Professor of Bioengineering and Human Genetics at the University of Utah, affiliated with the Scientific Computing and Imaging (SCI) Institute and Huntsman Cancer Institute. She is the Chief Scientific Officer and co-founder of Prism AI Therapeutics, Inc., and a member of the NCI-DOE Cancer Moonshot collaboration. Her research focuses on quantum mechanics-based AI/ML to derive clinically actionable predictors from multi-omic data. Key contributions include the 'eigengene' concept (PNAS top 50 cited paper) and tensor decompositions for genomic signal processing.

• Education: Ph.D. in Applied Physics from Stanford University (1999), Postdoctoral Fellowship in Genetics at Stanford.
• Research Interests: Multi-tensor algorithms, cancer diagnostics/prognostics, personalized medicine, gravitational wave detection contributions.

Awards: 2014 AAPM Science Council Session Winner, 2005 Linear Algebra Lecturer, finalist for 1998 APS Doctoral Thesis Award, DOE/Sloan Postdoctoral Fellowship, and multiple NIH/NSF grants.

Labs & Teams: Leads the Genomic Signal Processing Lab, collaborating with industry and academic partners on AI-driven cancer research. Active in the Physical Sciences in Oncology Network.